bear-stearns
(3)
Erick Kuebler and the business of keeping your head
From the Bear Stearns RIA platform to the leadership of Sanders Morris, Erick Kuebler has spent three decades working where investment plans meet trading decisions. His public commentary offers a useful place to begin: take a breath, then examine the details.
Elizabeth Czerepak
Elizabeth Czerepak is a life sciences finance executive with more than three decades in big pharma, venture capital, and public biotech. She is Chief Financial Officer and VP of Corporate Development at Mirror Biologics, a clinical-stage immunotherapy company in Wesley Chapel, Florida, where she also served as acting CEO from July 2024 to May 2025. Over her career she has helped raise hundreds of millions of dollars, taken companies public through IPOs and SPAC mergers, and worked on landmark pharma transactions including the search that led to BASF Pharma's sale to Abbott. She sits on the boards of Delcath Systems and TransCode Therapeutics.
Karl Kipke
Karl Kipke is the founder and CEO of HealthGrowth Pharmacy Solutions, an Austin, Texas company that gives independent and community pharmacies a single ecosystem of lending, advisory, group purchasing, and transition services. A former Wall Street banker who spent 11 years at Morgan Stanley and Bear Stearns before turning to venture investing, Kipke built HealthGrowth Capital into a direct lender for pharmacies and closed a $16.8 million debt-and-equity financing package in April 2020 to expand its reach to independent pharmacy owners across the United States.